I

IO Biotech
D

IOBT

1.24000
USD
0.09
(7.83%)
Market Closed
Volume
2,324
EPS
0
Div Yield
0
P/E
-1
Market Cap
81,692,333
News

Title: IO Biotech

Sector: Healthcare
Industry: Biotechnology
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.